Add
VETS to Portfolio
Set Alert
Email to a
Friend
| |||
|
|
Quotes & Info
|
| VETS > SEC Filings for VETS > Form 8-K on 3-Aug-2009 | All Recent SEC Filings |
3-Aug-2009
Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Tran
As previously disclosed in Pet DRx Corporation's (the "Company") Proxy Statement on Schedule 14A, filed with the Securities and Exchange Commission on July 9, 2009 (the "Proxy Statement"), Mr. Gary Brukardt informed the Company that he would retire from the Company's Board of Directors effective with the expiration of his annual term on July 28, 2009. Mr. Brukardt also served on our audit committee and, accordingly, Mr. Brukardt's retirement caused our audit committee to have only two members. As a result, we are currently noncompliant with NASDAQ Marketplace Rule 5605(c)(2)(A), which requires listed companies to have at least three (3) audit committee members. The Company gave notice to NASDAQ of this non-compliance on July 30, 2009 in accordance with Nasdaq rules.
On July 31, 2009, the Company received a Nasdaq staff deficiency letter confirming that the Company fails to comply with Nasdaq Marketplace Rule 5605 regarding the audit committee composition requirement as described above. The Nasdaq staff informed the Company that the Company has until the earlier of the date of its next annual shareholders meeting or July 28, 2010 to comply with this requirement (the "Cure Period"). The Board expects to appoint a new independent director to become a member of the audit committee prior to the expiration of the Cure Period at which time the Company expects to be in full compliance with NASDAQ Marketplace Rule 5605(c)(2)(A).
As previously disclosed in the Company's Proxy Statement, the Board determined that Messrs. Brukardt, Kanter, Johnston, and Martin are "independent" as that term is defined under the applicable rules and regulations of the Nasdaq Stock Market. The Company's Proxy Statement inadvertently omitted the fact that the Board also had determined that Mr. Shroff is "independent" under the applicable Nasdaq rules. The Board is currently comprised of six directors the majority of whom are independent under the applicable Nasdaq rules.
A copy of the press release announcing the Company's technical noncompliance with Nasdaq's audit committee composition requirement is filed as Exhibit 99.1 to this Current Report on Form 8-K.
(d) Exhibits
99.1 Copy of press release dated July 31, 2009 issued by Pet DRx Corporation.
|
|